High THC/No CBD Marihuana
Phase 1Small molecule
High THC/No CBD Marihuana is one of 41 small molecule programs targeting Memory. It is currently in Phase 1.
1
Indications
2
Total Trials
1
Active Trials
40
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
169 competitors in Memory
#DrugCompanyPhaseTrials
1Lexapro
AbbViePhase 3
Jatenzo
GGrupo Espanol de Tumores Neuroendocrinos
Phase 3
Vivarin
HHikma Pharmaceuticals LLC
Phase 3
Pneumococcal Vaccine
GSKPhase 3
Bupropion XL
GSKPhase 3
Epidiolex
Jazz PharmaceuticalsPhase 2
Cysteine Hydrochloride
NovartisPhase 2
Avandia
Alnylam PharmaceuticalsPhase 2
Rituxan
RochePhase 2
Activella
Eli LillyPhase 2
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for High THC/No CBD Marihuana. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Phase 1[1]
- Company
- HHartford Hospital